The Mediterranean diet, fish oil supplements and Rheumatoid arthritis outcomes: evidence from clinical trials.

  title={The Mediterranean diet, fish oil supplements and Rheumatoid arthritis outcomes: evidence from clinical trials.},
  author={Sara Danuta Petersson and Elena Philippou and Carrie Rodomar and Elena Nikiphorou},
  journal={Autoimmunity reviews},
  volume={17 11},

Tables from this paper

Rheumatoid arthritis and dietary interventions: systematic review of clinical trials.

Some dietary approaches may improve RA symptoms and thus it is recommended that nutrition should be routinely addressed.

Nutritional interventions and supplementation for rheumatoid arthritis patients: A systematic review for clinical application, Part 1: Dieting

Dietary interventions may be an effective method for reducing inflammation and symptoms associated with RA and clinicians should familiarize themselves with these triggers to educate their patients.

Nutrition as both risk factor and intervention in rheumatic diseases

The purpose of the paper is to provide a review of the effects of nutrition as a risk factor and intervention in the aspect of rheumatic diseases, using information analysis methods and there is a sufficient evidence base of preventive counse­ling of patients on nutritional issues with the aim of cardiovascular risk reduction.

Beverages in Rheumatoid Arthritis: What to Prefer or to Avoid

Beverages have a key role within the mosaic of autoimmunity in RA and potential to alter the microbiome, leading to downstream effects on inflammatory pathways, and how this growing body of evidence may be harnessed by the multidisciplinary team in patient management.

The effect of Omega-3 fatty acid supplementation in systemic lupus erythematosus patients: A systematic review

Current data show that there is a potential benefit on disease activity as demonstrated by SLAM-R, Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and British Isles Lupus Assessment Group (BILAG) scores and plasma membrane arachidonic acid composition and urinary 8-isoprostane levels, with minimal adverse events.

Fish oil supplementation and maintaining muscle mass in chronic disease: state of the evidence.

Overall, the evidence for an effect of fish oil supplementation on muscle mass in patients with cancer undergoing treatment and in COPD remains unequivocal and reveals limited new knowledge in the area ofFish oil supplementation in the cancer setting.

Improvement of Inflammation and Pain after Three Months’ Exclusion Diet in Rheumatoid Arthritis Patients

The results suggest that a privative diet can result in a better control of inflammation in RA patients under stable optimized drug treatment.

Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study

Results from this study evidenced that in PsA patients, higher levels of disease activity as measured by DAPSA correlated with low adherence to mediterranean diet, suggesting potential benefit of antinflammatory properties of this dietary pattern.

Diet as a Modulator of Intestinal Microbiota in Rheumatoid Arthritis

How the Mediterranean diet, a whole dietary pattern, could possibly act as an adjuvant therapeutic approach, modulating intestinal microbiota and intestinal barrier function in RA in order to improve RA-related outcomes is reviewed.



The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: a systematic review of human prospective studies

This review has identified beneficial effects of the Mediterranean diet in reducing pain and increasing physical function in people living with rheumatoid arthritis, however, there is currently insufficient evidence to support widespread recommendation of theiterranean diet for prevention of rhearatoid arthritis.

An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis

The results indicate that patients with RA, by adjusting to a Mediterranean diet, did obtain a reduction in inflammatory activity, an increase in physical function, and improved vitality.

Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects.

It is concluded that the clinical benefits of dietary supplementation with omega-3 fatty acids are more commonly observed in patients consuming higher dosages of fish oil for time intervals that are longer than those previously studied.

The effects of dietary supplementation with n‐3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial

Dietary supplementation with n‐3 PUFA in patients with rheumatoid arthritis improved two out of six patient reported disease parameters, and further studies are needed to clarify the more precise role of n‐2 polyunsaturated fatty acids in the treatment of rhearatoid arthritis.

Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis

A diet low in arachidonic acid ameliorates clinical signs of inflammation in patients with RA and augments the beneficial effect of fish oil supplementation.

Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates.

Patients taking dietary supplements of fish oil exhibit improvements in clinical parameters of disease activity from baseline, including the number of tender joints, and these improvements are associated with significant decreases in levels of IL-1 beta from baseline.

How the Mediterranean diet and some of its components modulate inflammatory pathways in arthritis.

Although some aspects concerning the mechanisms of action through which the Mediterranean diet pattern exerts its beneficial effects remain to be elucidated, arthritis patients may potentially benefit from it in view of their increased cardiovascular risk and the treatment they require which may have side effects.

Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis.

Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritis

Biomarkers of n-3 status, such as plasma PL EPA, have the potential to predict clinical outcomes relevant to standard drug treatment of RA patients.